| 1 | Colecalciferol D3 (Vigantol Oil) | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 |
| 2 | Vigantol | - | - | - | - | [4] 13 13, 65, 96, 97 |
| 3 | Vigantol Oel | - | - | - | - | [3] 13 13, 96, 97 |
| 4 | Vigantol Oel TM | - | - | - | - | [2] 96 96, 97 |
| 5 | VIGANTOL OIL | - | - | - | - | [1] 13 13 |
| 6 | VigantOL oil plus interferon beta-1a (Rebif) | [2] Human interferon beta Human interferon beta,
Interferon beta-1a | [1] D04554
D04554
| [2] IFNAR1 IFNAR1,
IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
| 7 | Vigantol® Oil | - | - | - | - | [1] 13 13 |
| 8 | Vigantol® Öl 20.000 I.E./ml | - | - | - | - | [1] 13 13 |